swog l-carnitine chemotherapy neuropathy Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy | Pharmacological Reports Guidelines for Chemotherapy-Induced Peripheral Neuropathy
Description
10.1111/j.1365-2672.1998.tb05269.x J
Volanesorsen is an antisense oligonucleotide targeting apoCIII mRNA, and it is developed for treatment of familial CM syndrome (FCS), HTG, and familial partial lipodystrophy (Gouni-Berthold, 2017
Purkayastha S
Activation of NMDA receptors leads to calcium release, increased nitric oxide production, and excitotoxicity
SNO of this protein leads to its phosphorylation at Ser616, and thus, activation of fission in hippocampal neurons [318]
[40] LRU static analysis does not extend to pseudo-LRU policies
